Canopy Growth Urges Shareholders to Cast Their Vote for the Upcoming Annual Meeting Today
Last Call For SNDL's Liquor President: Stock On The Rocks Amid Leadership Changes
Here's What the Harris-Trump Debate Means for US Stocks
Cannabis Stocks React To Trump's Marijuana Comments: See Which Ones Posted Solid Gains
Marijuana Stock Movers For September 9, 2024
Cannabis Stocks Rally After Trump Supports Moving Drug to Less Restrictive Category
Canada Net Change Percentage Gainers & Losers
Trump's Marijuana Support Could Ignite Stock Surge – Are You Positioned To Benefit?
American Views on Marijuana Effects Worsening: Gallup
Canopy Growth Introduces 'Smokeless September' Campaign
STORZ & BICKEL Debuts Inaugural "Smokeless September Challenge" to Educate Consumers on the Advantages of Vaporization
Canadian Stock Movers for Thursday
Here's Why Tilray Brands, Canopy Growth, Curaleaf Stocks Have Crashed
Cannabis Retailer Tokyo Smoke To Close 29 Stores In Canada As It Seeks Creditor Protection
Cannabis Stock Gainers And Losers From August 28, 2024
Canopy Growth's CEO Is Leaving: Is That a Sign of Trouble for the Cannabis Stock?
Canadian Stock Movers for Wednesday | National Bank of Canada Was the Top Gainer; Diversified Financial Services Led Gains
Ascend Wellness Becomes Third Cannabis Company to Jettison Its Chief Executive This Month
Cannabis Stocks Drop as DEA Sets Drug-rescheduling Hearing After November Election
The hearing on the reclassification of cannabis is approaching, and both US cannabis stocks and ETFs are under pressure.
The upcoming open hearing on December 2nd by the US Drug Enforcement Administration has attracted widespread attention from the market, and aims to discuss the proposal to reclassify marijuana.